News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
775,990 Results
Type
Article (54754)
Company Profile (398)
Press Release (720813)
Multimedia
Podcasts (159)
Webinars (23)
Section
Business (214595)
Career Advice (2248)
Deals (37977)
Drug Delivery (151)
Drug Development (86140)
Employer Resources (178)
FDA (17347)
Job Trends (15816)
News (365618)
Policy (35155)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (2849)
Academic (1)
Accelerated approval (48)
Adcomms (33)
Allergies (178)
Alliances (52913)
ALS (216)
Alzheimer's disease (1850)
Antibody-drug conjugate (ADC) (481)
Approvals (17672)
Artificial intelligence (734)
Autoimmune disease (289)
Automation (57)
Bankruptcy (384)
Best Places to Work (11957)
BIOSECURE Act (22)
Biosimilars (233)
Biotechnology (253)
Bladder cancer (190)
Brain cancer (77)
Breast cancer (775)
Cancer (6030)
Cardiovascular disease (486)
Career advice (1915)
Career pathing (44)
CAR-T (352)
CDC (66)
Celiac Disease (3)
Cell therapy (974)
Cervical cancer (47)
Clinical research (74049)
Collaboration (2170)
Company closure (6)
Compensation (1378)
Complete response letters (92)
COVID-19 (2919)
CRISPR (118)
C-suite (1151)
Cystic fibrosis (158)
Data (7817)
Decentralized trials (3)
Denatured (44)
Depression (174)
Dermatology (83)
Diabetes (598)
Diagnostics (7142)
Digital health (56)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (356)
Drug pricing (228)
Drug shortages (35)
Duchenne muscular dystrophy (293)
Earnings (94106)
Editorial (73)
Employer branding (21)
Employer resources (158)
Events (124897)
Executive appointments (1119)
FDA (21100)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1768)
Gene editing (249)
Generative AI (66)
Gene therapy (780)
GLP-1 (1147)
Government (5026)
Grass and pollen (7)
Guidances (407)
Healthcare (19650)
HIV (82)
Huntington's disease (61)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (100)
Immunology and inflammation (326)
Immuno-oncology (99)
Indications (181)
Infectious disease (3266)
Inflammatory bowel disease (232)
Inflation Reduction Act (15)
Influenza (141)
Intellectual property (293)
Interviews (363)
IPO (17151)
IRA (58)
Job creations (4183)
Job search strategy (1585)
JPM (68)
Kidney cancer (21)
Labor market (98)
Layoffs (632)
Leadership (43)
Legal (8687)
Liver cancer (106)
Longevity (33)
Lung cancer (802)
Lymphoma (435)
Machine learning (62)
Management (62)
Manufacturing (1088)
MASH (193)
Medical device (14262)
Medtech (14372)
Mergers & acquisitions (22070)
Metabolic disorders (1572)
mRNA (226)
Multiple sclerosis (192)
NASH (18)
Neurodegenerative disease (432)
Neuropsychiatric disorders (115)
Neuroscience (3424)
Neurotech (1)
NextGen: Class of 2026 (6895)
Non-profit (4712)
Now hiring (77)
Obesity (750)
Opinion (334)
Ovarian cancer (220)
Pain (267)
Pancreatic cancer (304)
Parkinson's disease (368)
Partnered (34)
Patents (610)
Patient recruitment (679)
Peanut (64)
People (62544)
Pharmaceutical (96)
Pharmacy benefit managers (35)
Phase 1 (23126)
Phase 2 (32537)
Phase 3 (24296)
Pipeline (8363)
Policy (344)
Postmarket research (2751)
Preclinical (10139)
Press Release (71)
Prostate cancer (303)
Psychedelics (64)
Radiopharmaceuticals (341)
Rare diseases (1140)
Real estate (6468)
Recruiting (73)
Regulatory (26986)
Reports (58)
Research institute (2622)
Resumes & cover letters (382)
Rett syndrome (37)
RNA editing (23)
RSV (91)
Schizophrenia (189)
Series A (307)
Series B (216)
Service/supplier (12)
Sickle cell disease (120)
Special edition (30)
Spinal muscular atrophy (176)
Sponsored (49)
Startups (3925)
State (2)
Stomach cancer (21)
Supply chain (132)
Tariffs (101)
The Weekly (112)
Vaccines (1171)
Venture capital (112)
Weight loss (499)
Women's health (125)
Worklife (20)
Date
Today (205)
Last 7 days (900)
Last 30 days (3303)
Last 365 days (31672)
2026 (11816)
2025 (31811)
2024 (36730)
2023 (41342)
2022 (52648)
2021 (57211)
2020 (55692)
2019 (48520)
2018 (36737)
2017 (34166)
2016 (33857)
2015 (39826)
2014 (33710)
2013 (29300)
2012 (31305)
2011 (31767)
2010 (29915)
Location
Africa (866)
Alabama (91)
Alaska (7)
Arizona (356)
Arkansas (16)
Asia (44688)
Australia (7435)
California (13204)
Canada (3747)
China (1386)
Colorado (573)
Connecticut (571)
Delaware (405)
Europe (97704)
Florida (1975)
Georgia (421)
Hawaii (3)
Idaho (66)
Illinois (1070)
India (91)
Indiana (608)
Iowa (24)
Japan (534)
Kansas (135)
Kentucky (53)
Louisiana (43)
Maine (87)
Maryland (1599)
Massachusetts (9604)
Michigan (364)
Minnesota (720)
Mississippi (6)
Missouri (145)
Montana (34)
Nebraska (30)
Nevada (141)
New Hampshire (89)
New Jersey (3489)
New Mexico (31)
New York (3500)
North Carolina (1712)
North Dakota (10)
Northern California (6564)
Ohio (396)
Oklahoma (24)
Oregon (47)
Pennsylvania (2661)
Puerto Rico (30)
Rhode Island (50)
South America (1264)
South Carolina (86)
South Dakota (2)
Southern California (5189)
Tennessee (211)
Texas (2110)
United States (47016)
Utah (395)
Vermont (1)
Virginia (330)
Washington D.C. (83)
Washington State (1072)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
775,990 Results for "cell pathways inc acquired by osi pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc.
April 7, 2026
·
7 min read
Press Releases
Fortitude Biomedicines Announces Lead Program Targeting Disease-Driven T-cell Signaling Pathways for the Treatment of Axial Spondyloarthritis
April 7, 2026
·
3 min read
Press Releases
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
April 20, 2026
·
6 min read
Press Releases
UCB to Acquire Candid Therapeutics, Building Upon Its Existing Immunology Pipeline With Novel T-cell Engagers
May 4, 2026
·
9 min read
Press Releases
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.
April 24, 2026
·
6 min read
Complete response letters
Incyte’s Lung Cancer Expansion Bid Thwarted by Issues at Novo’s Catalent-Acquired Site
Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did not flag problems with the drug’s efficacy or safety.
March 9, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products
April 15, 2026
·
7 min read
Press Releases
Gallant Reports Positive Pilot Data for Feline Osteoarthritis Stem Cell Therapy; Receives FDA Eligibility for Expanded Conditional Approval Pathway
April 15, 2026
·
1 min read
Layoffs
50 employees impacted as Astellas closes Universal Cells’ Seattle office
By closing the Universal Cells Seattle location, Astellas is reportedly consolidating cell therapy, gene therapy and oncology research at its South San Francisco, California, and Westborough, Massachusetts, sites.
April 14, 2026
·
2 min read
·
Angela Gabriel
Press Releases
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)
March 25, 2026
·
13 min read
1 of 77,599
Next
